Latest Regulatory News

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Condor Energy Limited has advanced its offshore Peru portfolio with a new high-potential oil prospect and a strategic gas offtake agreement, positioning itself for future commercialisation in a promising basin.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

Prodigy Gold NL reported significant gold intercepts from its Tanami North Project, alongside environmental baseline studies and a new 3D structural collaboration with CSIRO, positioning the company for future mining development.

WAM Income Maximiser Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.0045 per share for January 2026 and setting the Dividend Reinvestment Plan price at AUD 1.61973.

Osteopore Limited has secured an exclusive agreement with MontsMed Hong Kong to introduce its innovative 3D-printed orthopaedic implants into Hong Kong, positioning itself strategically within the Greater Bay Area’s burgeoning medical market.

The ASX has released its latest list of entities suspended from trading for over three months, highlighting looming deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines could lead to removal from the official list.

Codeifai Limited has responded to an ASX price query denying any undisclosed information behind recent unusual trading activity, while highlighting its nearing completion of the Antenna Transfer acquisition.

NH3 Clean Energy has marked significant progress in its WAH2 clean ammonia project, securing major offtake agreements and government facilitation support alongside a $4 million institutional funding round.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.

N1 Holdings Limited has reported a strong December quarter with rising revenue, net profit, and cash receipts, underpinned by SME lending growth and funding efficiency improvements. The company also navigates increased regulatory scrutiny with a firm commitment to conservative lending.

Alternative Investment Trust (ASX, AIQ) has announced a special unfranked distribution of 3.559 cents per unit, representing a full return of capital payable in February 2026.